SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ:CYTX) received 510(k) regulatory clearance from the Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) for the Cytori Autologous Fat Transfer (AFT) System. This system may be used to harvest, filter, and transfer a patient’s own adipose (fat) tissue from one part of a patient’s body to another at the point-of-care in the same surgical procedure.
